Tirzepatide is a synthetic peptide analog widely utilized in laboratory research for the study of dual incretin receptor activity, specifically targeting glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. It is commonly investigated for its role in modulating complex metabolic signaling pathways, receptor binding dynamics, and endocrine system interactions within controlled experimental models.
In research environments, Tirzepatide is used to explore mechanisms related to glucose metabolism, insulin signaling, and energy balance regulation at the cellular level. Its dual-receptor activity makes it particularly valuable for analyzing coordinated signaling responses, downstream pathway activation, and hormonal feedback mechanisms. This compound is also of interest in broader studies focused on receptor synergy, metabolic pathway integration, and cellular response modulation across repeatable laboratory protocols.
Reconstitution (For Research Reference Only):
Add 2mL of bacteriostatic water to achieve a concentration of 10mg/mL. At this concentration, each 0.1mL (10 units on a standard insulin syringe) corresponds to 1mg of compound. This information is provided strictly for laboratory research standardization and measurement purposes.
This product is supplied in lyophilized (freeze-dried) form within a sealed vial to ensure stability and precision in handling. It is intended exclusively for laboratory research, analytical, and educational purposes and is not approved for—and must not be used for—human or animal consumption.



